Covered recipient · General Payments record
STEPHENIE V BRINSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,610.41
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $850.64 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $328.71 | 10 |
| Acerta Pharma LLC | $176.56 | 5 |
| Amgen Inc. | $138.27 | 2 |
| PFIZER INC. | $69.50 | 3 |
| Novo Nordisk AS | $60.47 | 3 |
| Lilly USA, LLC | $28.59 | 2 |
| GlaxoSmithKline, LLC. | $17.99 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.57 | 1 |
| Phadia US Inc. | $14.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $115.42 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369453 | CMS |
| ABBVIE INC. | $4.22 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369455 | CMS |
| ABBVIE INC. | $21.77 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369457 | CMS |
| ABBVIE INC. | $19.91 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369459 | CMS |
| ABBVIE INC. | $6.19 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369461 | CMS |
| ABBVIE INC. | $106.88 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369463 | CMS |
| ABBVIE INC. | $5.61 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369465 | CMS |
| ABBVIE INC. | $21.01 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369467 | CMS |
| ABBVIE INC. | $8.91 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369469 | CMS |
| ABBVIE INC. | $18.79 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369471 | CMS |
| Amgen Inc. | $13.27 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117514033 | CMS |
| Amgen Inc. | $125.00 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117210122 | CMS |
| AstraZeneca Pharmaceuticals LP | $116.99 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119661873 | CMS |
| AstraZeneca Pharmaceuticals LP | $10.77 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119661099 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.53 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119661461 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.48 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119659136 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.79 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119660955 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.57 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086347421 | CMS |
| GlaxoSmithKline, LLC. | $17.99 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116416792 | CMS |
| Lilly USA, LLC | $13.69 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135959457 | CMS |
| Lilly USA, LLC | $14.90 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135946973 | CMS |
| Novo Nordisk Inc | $18.15 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100548186 | CMS |
| Novo Nordisk Inc | $20.33 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100550878 | CMS |
| Novo Nordisk Inc | $21.99 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100308327 | CMS |
| PFIZER INC. | $19.88 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131008096 | CMS |
| PFIZER INC. | $19.80 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131764392 | CMS |
| PFIZER INC. | $29.82 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132086610 | CMS |
| Phadia US Inc. | $14.98 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067586900 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.